Latest MediciNova News & Updates

See the latest news and media coverage for MediciNova. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
MediciNova

Biopharmaceutical company developing novel therapeutics

medicinova.com
Headquarters
La Jolla, United States
Company type
Public company
Number of employees
15–50

Latest news about MediciNova

Company announcements

  • MediciNova

    MediciNova collaborates with Mayo Clinic on ALS program

    The SEANOBI EAP evaluates MN-166 (ibudilast) for ALS patients, generating real-world data complementing the COMBAT-ALS study.

  • MediciNova

    MediciNova announces peer-reviewed study on ibudilast for brain metastasis

    The study identifies MIF-CD74 signaling as a target, showing ibudilast suppresses metastasis in preclinical models. MediciNova plans clinical collaboration with CNIO.

  • MediciNova

    MediciNova advances MN-166 trial for ALS

    The Phase 2B/3 study evaluates slowing progression, improving outcomes, and extending survival in ALS patients.

  • MediciNova

    MediciNova evaluates ibudilast in ALS trial

    Ibudilast, approved in Japan for over 20 years with a strong safety profile, is tested in Phase 2b/3 trial to slow ALS progression, improve function, and extend survival.

Unlock all announcements with a

Media coverage

Unlock all articles with a

Never miss news about MediciNova

Track MediciNova and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

MediciNova competitors & trending companies

Browse news for competitors to MediciNova and other trending companies.